Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Does Cannabis Interact with SSRIs or SNRIs For Depression Treatment? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

Research into cannabis and SSRI interactions in depression is still limited, but there are concerns that combining cannabis with antidepressants may alter how these medicines work. Both SSRIs and SNRIs affect serotonin pathways, while cannabinoids also influence brain chemistry, raising the possibility of overlapping effects. 

Doctors caution that using cannabis alongside antidepressants could increase side effects such as drowsiness, dizziness, or mood fluctuations. While not everyone experiences problems, the potential for interaction means careful monitoring is advised. 

Is Medical Cannabis Legal in UK?

Possible Interaction Risks 

Studies on cannabis and SSRI interactions highlight several areas where overlap with antidepressants may occur. These issues are still under investigation but are important for patients to be aware of. 

Drug Interactions 

One concern is drug interactions at the metabolic level. Both antidepressants and cannabinoids are processed in the liver, meaning cannabis could affect how long SSRIs or SNRIs stay active in the body. 

Antidepressant Interaction 

There is also the possibility of a direct antidepressant interaction. Combining cannabis with these medications may intensify sedation or, in some cases, interfere with mood regulation, leading to unpredictable outcomes. 

Pharmacology 

From a pharmacology perspective, both cannabis and antidepressants act on brain receptors linked to serotonin and mood. This overlap raises questions about whether cannabis could amplify or blunt the intended effects of prescribed treatments. 

In summary, while clear data is still lacking, cannabis and SSRI interactions cannot be ruled out. Patients should be cautious and seek medical guidance before combining these treatments. 

For individuals considering cannabis while taking antidepressants, providers like LeafEase can offer careful consultations to discuss safety and tailored options. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Depression. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories